{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:44:39Z","timestamp":1792568679931,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02719-z","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:50:58Z","timestamp":1780311058000},"page":"1669-1681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Converging TCF7L2 and CDKAL1 pathways in the pathogenesis of type 2 diabetes mellitus"],"prefix":"10.1007","volume":"63","author":[{"given":"Meena S.","family":"Farman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam I.","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-8114","authenticated-orcid":false,"given":"Omar M.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2719_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garc\u00eda","year":"2020","unstructured":"Galicia-Garc\u00eda U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Mart\u00edn C (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21:6275. https:\/\/doi.org\/10.3390\/ijms21176275","journal-title":"Int J Mol Sci"},{"key":"2719_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1210\/clinem\/dgaa653","volume":"106","author":"HA Deshmukh","year":"2021","unstructured":"Deshmukh HA, Colhoun HM, Johnson PCD, Nair V, Gaynor P, McKeigue PM et al (2021) Genome-wide association analysis of pancreatic \u03b2-cell glucose sensitivity. J Clin Endocrinol Metab 106:80\u201390. https:\/\/doi.org\/10.1210\/clinem\/dgaa653","journal-title":"J Clin Endocrinol Metab"},{"key":"2719_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00125-021-05618-w","volume":"65","author":"JWJ Beulens","year":"2022","unstructured":"Beulens JWJ, Pinho MGM, Abreu TC, den Braver NR, Lam TM, Huss A et al (2022) Environmental risk factors of type 2 diabetes\u2013an exposome approach. Diabetologia 65:263\u2013274. https:\/\/doi.org\/10.1007\/s00125-021-05618-w","journal-title":"Diabetologia"},{"key":"2719_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1501690","volume":"15","author":"KJ He","year":"2024","unstructured":"He KJ, Bai J, Liu Y, Zhang Y, Li X, Tang Y, Ma Z, Hu Y (2024) Global burden of type 2 diabetes mellitus from 1990 to 2021 and projections to 2050: an age\u2013period\u2013cohort analysis based on GBD 2021. Front Endocrinol (Lausanne) 15:1501690. https:\/\/doi.org\/10.3389\/fendo.2024.1501690","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2719_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/20552076241271722","volume":"10","author":"X Cao","year":"2024","unstructured":"Cao X, Ma J, Zhou H, Wang Y, Zhang W (2024) An overview of environmental risk factors for type 2 diabetes mellitus. Digit Health 10:20552076241271722. https:\/\/doi.org\/10.1177\/20552076241271722","journal-title":"Digit Health"},{"key":"2719_CR6","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s00125-025-06499-z","volume":"68","author":"B Yau","year":"2025","unstructured":"Yau B, Ghislain J, Kebede MA, Hughes J, Poitout V (2025) The role of the beta cell in type 2 diabetes: new findings from the last 5 years. Diabetologia 68:2092\u20132103. https:\/\/doi.org\/10.1007\/s00125-025-06499-z","journal-title":"Diabetologia"},{"key":"2719_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtumed.2024.04.005","volume":"19","author":"AH Younus","year":"2024","unstructured":"Younus AH, Al-Faisal AHM (2024) Correlation between TCF7L2 gene expression and certain biochemical parameters in type 2 diabetes mellitus. J Taibah Univ Med Sci 19:575\u2013584. https:\/\/doi.org\/10.1016\/j.jtumed.2024.04.005","journal-title":"J Taibah Univ Med Sci"},{"key":"2719_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.783078","volume":"12","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Zou D, Gu S, Han F, Cao S, Wei Y, Guo R (2022) Different associations between CDKAL1 variants and type 2 diabetes mellitus susceptibility: a meta-analysis. Front Genet 12:783078. https:\/\/doi.org\/10.3389\/fgene.2021.783078","journal-title":"Front Genet"},{"key":"2719_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/genes11101122","volume":"11","author":"RB Prasad","year":"2020","unstructured":"Prasad RB, Groop L (2020) Genetics of type 2 diabetes\u2014pitfalls and possibilities. Genes (Basel) 11:1122. https:\/\/doi.org\/10.3390\/genes11101122","journal-title":"Genes (Basel)"},{"key":"2719_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1212716","volume":"14","author":"J Cha","year":"2023","unstructured":"Cha J, Aguayo-Mazzucato C, Thompson PJ (2023) Pancreatic \u03b2-cell senescence in diabetes: mechanisms, markers and therapies. Front Endocrinol (Lausanne) 14:1212716. https:\/\/doi.org\/10.3389\/fendo.2023.1212716","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2719_CR11","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1530\/JOE-21-0067","volume":"250","author":"JM Ikle","year":"2021","unstructured":"Ikle JM, Gannon M, Kahn CR (2021) 100 years of insulin: a brief history of diabetes genetics. J Endocrinol 250:E1\u2013E18. https:\/\/doi.org\/10.1530\/JOE-21-0067","journal-title":"J Endocrinol"},{"key":"2719_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2021.0045","volume":"46","author":"S Asahara","year":"2022","unstructured":"Asahara S, Inoue H, Teruyama K, Kawada Y, Kawaguchi M, Matsuda T (2022) Regulation of pancreatic \u03b2-cell mass by gene transcription, growth factors and hormones. Diabetes Metab J 46:1\u201314. https:\/\/doi.org\/10.4093\/dmj.2021.0045","journal-title":"Diabetes Metab J"},{"key":"2719_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2025\/5521613","volume":"2025","author":"R Wang","year":"2025","unstructured":"Wang R, Li Y, Chen X, Zhang L, Huang J (2025) Disease burden of type 2 diabetes among young adults in Asia, 1990\u20132021: results from GBD 2021. J Diabetes Res 2025:5521613. https:\/\/doi.org\/10.1155\/2025\/5521613","journal-title":"J Diabetes Res"},{"key":"2719_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15162110","volume":"15","author":"Y-C Lu","year":"2025","unstructured":"Lu Y-C, Lin C-H, Chen Y-W, Yang S-Y, Chang C-W (2025) Association of TCF7L2 rs7903146 (C\/T) polymorphism with type 2 diabetes mellitus and metabolic traits in a Han Chinese population. Diagnostics (Basel) 15:2110. https:\/\/doi.org\/10.3390\/diagnostics15162110","journal-title":"Diagnostics (Basel)"},{"key":"2719_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba3066","volume":"369","author":"M Oliva","year":"2020","unstructured":"Oliva M, Mu\u00f1oz-Aguirre M, Kim-Hellmuth S, Wucher V, Gewirtz ADH, Cotter DJ, Parsana P, Kasela S, Balliu B, Vi\u00f1uela A, Castel SE, Mohammadi P, Aguet F, Lappalainen T (2020) The impact of sex on gene expression across human tissues and its relevance to metabolic disease. Science 369:eaba3066. https:\/\/doi.org\/10.1126\/science.aba3066","journal-title":"Science"},{"key":"2719_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18581-8","volume":"11","author":"A Vi\u00f1uela","year":"2020","unstructured":"Vi\u00f1uela A, Varshney A, van de Bunt M, Pratanwanich PN, Eraslan G, Mathieson I, Stegle O, McCarthy MI (2020) Genetic variant effects on gene expression in human pancreatic islets and their implications for type 2 diabetes. Nat Commun 11:4912. https:\/\/doi.org\/10.1038\/s41467-020-18581-8","journal-title":"Nat Commun"},{"key":"2719_CR17","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1007\/s00125-023-05956-x","volume":"66","author":"MA Nauck","year":"2023","unstructured":"Nauck MA (2023) Incretin hormones and type 2 diabetes. Diabetologia 66:1736\u20131751. https:\/\/doi.org\/10.1007\/s00125-023-05956-x","journal-title":"Diabetologia"},{"key":"2719_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092217","volume":"15","author":"A Serbis","year":"2023","unstructured":"Serbis A, Giapros V, Tsamis K, Balomenou F, Galli-Tsinopoulou A, Siomou E (2023) Beta cell dysfunction in youth- and adult-onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients. Nutrients 15:2217. https:\/\/doi.org\/10.3390\/nu15092217","journal-title":"Nutrients"},{"key":"2719_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, Park S-Y, Choi C-S (2022) Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J 46:15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280","journal-title":"Diabetes Metab J"},{"key":"2719_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, Zhang Y, Shen S, Tong N (2024) Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther 9:262. https:\/\/doi.org\/10.1038\/s41392-024-01951-9","journal-title":"Signal Transduct Target Ther"},{"key":"2719_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111905","volume":"217","author":"N Rabbani","year":"2024","unstructured":"Rabbani N, Thornalley PJ (2024) Unraveling the impaired incretin effect in obesity and type 2 diabetes: key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload. Diabetes Res Clin Pract 217:111905. https:\/\/doi.org\/10.1016\/j.diabres.2024.111905","journal-title":"Diabetes Res Clin Pract"},{"key":"2719_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF02427280","volume":"29","author":"MA Nauck","year":"1986","unstructured":"Nauck MA, Stockmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 diabetic patients. Diabetologia 29:46\u201352. https:\/\/doi.org\/10.1007\/BF02427280","journal-title":"Diabetologia"},{"key":"2719_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/genes12060809","volume":"12","author":"L del Bosque-Plata","year":"2021","unstructured":"del Bosque-Plata L, Mart\u00ednez-Mart\u00ednez E, Espinoza-Camacho MA, Gragnoli C (2021) The role of TCF7L2 in type 2 diabetes: molecular mechanisms and clinical implications. Genes (Basel) 12:809. https:\/\/doi.org\/10.3390\/genes12060809","journal-title":"Genes (Basel)"},{"key":"2719_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1254968","volume":"2021","author":"N Xu","year":"2021","unstructured":"Xu N, Zhang TT, Han WJ, Li L, Shen Y (2021) Association of CDKAL1 rs10946398 gene polymorphism with susceptibility to diabetes mellitus type 2: a meta-analysis. J Diabetes Res 2021:1254968. https:\/\/doi.org\/10.1155\/2021\/1254968","journal-title":"J Diabetes Res"},{"key":"2719_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00125-006-0590-z","volume":"50","author":"DR Laybutt","year":"2007","unstructured":"Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, Biden TJ (2007) Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50:752\u2013763. https:\/\/doi.org\/10.1007\/s00125-006-0590-z","journal-title":"Diabetologia"},{"key":"2719_CR26","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v96i2.16415","volume":"96","author":"M Atoum","year":"2025","unstructured":"Atoum M, Almehsen A (2025) CDKAL1 gene variants (rs7756992 and rs10946398) and susceptibility to type 2 diabetes: evidence from a Jordanian case-control study. Acta Biomed 96:16415. https:\/\/doi.org\/10.23750\/abm.v96i2.16415","journal-title":"Acta Biomed"},{"key":"2719_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2024.100184","volume":"6","author":"KC Mbara","year":"2024","unstructured":"Mbara KC, Fotsing MCD, Ndinteh DT, Mbeb CN, Nwagwu CS, Khan R, Mokhetho KC, Baijnath H, Nlooto M, Mokhele S, Leonard CM, Tembu VJ, Tarirai C (2024) Endoplasmic reticulum stress in pancreatic \u03b2-cell dysfunction: the potential therapeutic role of dietary flavonoids. Current Research in Pharmacology and Drug Discovery 6:100184. https:\/\/doi.org\/10.1016\/j.crphar.2024.100184","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"key":"2719_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s00125-020-05113-8","volume":"63","author":"O Silverman-Retana","year":"2020","unstructured":"Silverman-Retana O, Hulman A, Nielsen J, Ekstr\u00f8m CT, Carstensen B, Simmons RK, Bjerg L, Johnston LW, Witte DR (2020) Effect of familial diabetes status and age at diagnosis on type 2 diabetes risk: a nation-wide register-based study from Denmark. Diabetologia 63:934\u2013943. https:\/\/doi.org\/10.1007\/s00125-020-05113-8","journal-title":"Diabetologia"},{"key":"2719_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cjdd.2021.05.009","volume":"46","author":"M Akbarzadeh","year":"2022","unstructured":"Akbarzadeh M, Riahi P, Ramezankhani A, Rasekhi Dehkordi S, Amiri Roudbar M, Zarkesh M, Guity K, Khalili D, Zahedi AS, Azizi F, Daneshpour MS (2022) Parental transmission plays the major role in high aggregation of type 2 diabetes in Iranian families: Tehran Lipid and Glucose Study. Can J Diabetes 46:60\u201368. https:\/\/doi.org\/10.1016\/j.cjdd.2021.05.009","journal-title":"Can J Diabetes"},{"key":"2719_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu14153201","volume":"14","author":"M Laakso","year":"2022","unstructured":"Laakso M, Kuusisto J (2022) Genetics of type 2 diabetes: past, present and future. Nutrients 14:3201. https:\/\/doi.org\/10.3390\/nu14153201","journal-title":"Nutrients"},{"key":"2719_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s43042-023-00448-4","volume":"24","author":"KNJ Musafer","year":"2023","unstructured":"Musafer KNJ, Rava M, Sabah Chobok A, Shamsuddin S, Al-Mousawi MRR, Hayup F (2023) A meta-analysis and review on genetic mapping of type 2 diabetes mellitus in Iraq. Egypt J Med Hum Genet 24:66. https:\/\/doi.org\/10.1186\/s43042-023-00448-4","journal-title":"Egypt J Med Hum Genet"},{"key":"2719_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01855-1","volume":"17","author":"AA Elashi","year":"2024","unstructured":"Elashi AA, Toor SM, Umlai UKI, Al-Sarraj YA, Taheri S, Suhre K, Abou-Samra AB, Albagha OME (2024) Genome-wide association study and trans-ethnic meta-analysis identify novel susceptibility loci for type 2 diabetes mellitus. BMC Med Genomics 17:115. https:\/\/doi.org\/10.1186\/s12920-024-01855-1","journal-title":"BMC Med Genomics"},{"key":"2719_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00125-022-05848-6","volume":"66","author":"H Kim","year":"2023","unstructured":"Kim H, Westerman KE, Smith K, von Grotthuss M, Kwak SH, Kim J, Mercader JM, Florez JC, Gaulton K, Manning AK, Udler MS (2023) High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease. Diabetologia 66:495\u2013507. https:\/\/doi.org\/10.1007\/s00125-022-05848-6","journal-title":"Diabetologia"},{"key":"2719_CR34","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","volume":"28","author":"ATN Nair","year":"2022","unstructured":"Nair ATN, Wesolowska-Andersen A, Brorsson C, van de Bunt M, Abbasi A, Groop L (2022) Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nat Med 28:982\u2013988. https:\/\/doi.org\/10.1038\/s41591-022-01790-7","journal-title":"Nat Med"},{"key":"2719_CR35","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00125-025-06419-1","volume":"68","author":"RB Prasad","year":"2025","unstructured":"Prasad RB, Hakaste L, Tuomi T (2025) Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities. Diabetologia 68:1361\u20131374. https:\/\/doi.org\/10.1007\/s00125-025-06419-1","journal-title":"Diabetologia"},{"key":"2719_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","volume":"54","author":"A Mahajan","year":"2022","unstructured":"Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW et al (2022) Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet 54:560\u2013572. https:\/\/doi.org\/10.1038\/s41588-022-01058-3","journal-title":"Nat Genet"},{"key":"2719_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/2025.11.24.25340878","author":"K Taylor","year":"2025","unstructured":"Taylor K, Huerta-Chagoya A, Wang X, Vora M, Li J, Turk L, Genes & Health Research Team et al (2025) Improving type 2 diabetes polygenic risk scores by incorporating rare, low-frequency, and population-specific variants. medRxiv. https:\/\/doi.org\/10.1101\/2025.11.24.25340878","journal-title":"medRxiv"},{"key":"2719_CR38","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2337\/db17-0318","volume":"67","author":"X Chen","year":"2018","unstructured":"Chen X, Ayala II, Shannon C, Fourcaudot M, Acharya NK, Jenkinson CP, Heikkinen S, Norton L (2018) The diabetes gene and Wnt pathway effector TCF7L2 regulates adipocyte development and function. Diabetes 67:554\u2013568. https:\/\/doi.org\/10.2337\/db17-0318","journal-title":"Diabetes"},{"key":"2719_CR39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40200-021-00953-6","volume":"21","author":"C Ghosh","year":"2022","unstructured":"Ghosh C, Das N, Saha S, Kundu T, Sircar D, Roy P (2022) Involvement of Cdkal1 in the etiology of type 2 diabetes mellitus and microvascular diabetic complications: a review. J Diabetes Metab Disord 21:991\u20131001. https:\/\/doi.org\/10.1007\/s40200-021-00953-6","journal-title":"J Diabetes Metab Disord"},{"key":"2719_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.51248\/.v43i02.2089","volume":"43","author":"S Chowdhry","year":"2023","unstructured":"Chowdhry S, Sonkar GK, Manger PT, Khan MM, Alam R, Khan S (2023) To unravel the role of TCF7L2 (Transcription Factor 7 like 2) variants in type 2 diabetes mellitus. Biomedicine 43:535\u2013540. https:\/\/doi.org\/10.51248\/.v43i02.2089","journal-title":"Biomedicine"},{"key":"2719_CR41","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/dom.16193","volume":"27","author":"AL Hansen","year":"2025","unstructured":"Hansen AL, Andersen MK, Engelhard LM, Br\u00f8ns C, Hansen T, Nielsen JS, Vestergaard P, H\u00f8jlund K, Jessen N, Olsen MH, Thomsen RW, Vaag A (2025) Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes. Diabetes Obes Metab 27:2002\u20132011. https:\/\/doi.org\/10.1111\/dom.16193","journal-title":"Diabetes Obes Metab"},{"key":"2719_CR42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52709","volume":"16","author":"S Kumar","year":"2024","unstructured":"Kumar S, Prakash P, Kumari R, Kumar N (2024) Genetic association of transcription factor 7-like-2 rs7903146 polymorphism with type 2 diabetes mellitus. Cureus 16:e52709. https:\/\/doi.org\/10.7759\/cureus.52709","journal-title":"Cureus"},{"key":"2719_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1513088","volume":"12","author":"MS Al-Odinan","year":"2025","unstructured":"Al-Odinan MS, Alharbi K, Alshammari K, Alanzi F, Alatawi A, Almazyad M (2025) Interaction between the TCF7L2 gene and dietary intake on metabolic-syndrome risk factors among Saudi Arabian adults. Front Nutr 12:1513088. https:\/\/doi.org\/10.3389\/fnut.2025.1513088","journal-title":"Front Nutr"},{"key":"2719_CR44","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.2337\/db24-0192","volume":"73","author":"M Zeini","year":"2024","unstructured":"Zeini M, Laurenti MC, Egan AM, Muthusamy K, Ramar A, Vella E, Bailey KR, Cobelli C, Dalla Man C, Vella A (2024) The longitudinal effect of diabetes-associated variation in TCF7L2 on islet function in humans. Diabetes 73:1440\u20131446. https:\/\/doi.org\/10.2337\/db24-0192","journal-title":"Diabetes"},{"key":"2719_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002986","volume":"8","author":"KJ Oh","year":"2012","unstructured":"Oh KJ, Park J, Kim SS, Oh H, Choi CS, Koo SH (2012) TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver. PLoS Genet 8:e1002986. https:\/\/doi.org\/10.1371\/journal.pgen.1002986","journal-title":"PLoS Genet"},{"key":"2719_CR46","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00125-009-1640-0","volume":"53","author":"L Prokunina-Olsson","year":"2010","unstructured":"Prokunina-Olsson L, Hall JL (2010) Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut. Diabetologia 53:712\u2013716. https:\/\/doi.org\/10.1007\/s00125-009-1640-0","journal-title":"Diabetologia"},{"key":"2719_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2337\/db12-0365","volume":"62","author":"W Shao","year":"2013","unstructured":"Shao W, Wang D, Chiang YT, Ip W, Zhu L, Xu F, Columbus J, Belsham DD, Irwin DM, Zhang H, Wen X, Wang Q, Jin T (2013) The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis. Diabetes 62:789\u2013800. https:\/\/doi.org\/10.2337\/db12-0365","journal-title":"Diabetes"},{"key":"2719_CR48","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s42255-024-01140-6","volume":"6","author":"AL Madsen","year":"2024","unstructured":"Madsen AL, Bon\u00e0s-Guarch S, Gheibi S, Prasad R, Vangipurapu J, Ahuja V et al (2024) Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology. Nat Metab 6:1897\u20131912. https:\/\/doi.org\/10.1038\/s42255-024-01140-6","journal-title":"Nat Metab"},{"key":"2719_CR49","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1074\/jbc.M706105200","volume":"283","author":"Z Liu","year":"2008","unstructured":"Liu Z, Habener JF (2008) Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 283:8723\u20138735. https:\/\/doi.org\/10.1074\/jbc.M706105200","journal-title":"J Biol Chem"},{"key":"2719_CR50","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2337\/db08-1187","volume":"58","author":"G da Silva Xavier","year":"2009","unstructured":"da Silva Xavier G, Loder MK, McDonald A, Tarasov AI, Carzaniga R, Kronenberger K, Barg S, Rutter GA (2009) TCF7L2 regulates late events in insulin secretion from pancreatic islet beta cells. Diabetes 58:894\u2013905. https:\/\/doi.org\/10.2337\/db08-1187","journal-title":"Diabetes"},{"key":"2719_CR51","doi-asserted-by":"publisher","first-page":"20062","DOI":"10.1038\/s41598-024-70674-2","volume":"14","author":"K Yanasegaran","year":"2024","unstructured":"Yanasegaran K, Ng JYE, Chua EW, Nawi AM, Ng PY, Abdul Manaf MR (2024) Single nucleotide polymorphisms that are associated with obesity and type 2 diabetes among Asians: a systematic review and meta-analysis. Sci Rep 14:20062. https:\/\/doi.org\/10.1038\/s41598-024-70674-2","journal-title":"Sci Rep"},{"key":"2719_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jcp.30581","volume":"237","author":"L del Bosque-Plata","year":"2022","unstructured":"del Bosque-Plata L, Hern\u00e1ndez-Cort\u00e9s EP, Gragnoli C (2022) The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes. J Cell Physiol 237:301\u2013312. https:\/\/doi.org\/10.1002\/jcp.30581","journal-title":"J Cell Physiol"},{"key":"2719_CR53","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jdi.14149","volume":"15","author":"M Imamura","year":"2024","unstructured":"Imamura M, Maeda S (2024) Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine. J Diabetes Investig 15:410\u2013422. https:\/\/doi.org\/10.1111\/jdi.14149","journal-title":"J Diabetes Investig"},{"key":"2719_CR54","doi-asserted-by":"publisher","first-page":"584228","DOI":"10.3389\/fmolb.2020.584228","volume":"7","author":"A Narendran","year":"2021","unstructured":"Narendran A, Vangaveti S, Ranganathan SV, Eruysal E, Craft M, Alrifai O, Chua FY, Sarachan K, Litwa B, Ramachandran S, Agris PF (2021) Silencing of the tRNA Modification Enzyme Cdkal1 Effects Functional Insulin Synthesis in NIT-1 Cells: tRNALys3 Lacking ms2- (ms2t6A37) is Unable to Establish Sufficient Anticodon:Codon Interactions to Decode the Wobble Codon AAG. Front Mol Biosci 7:584228. https:\/\/doi.org\/10.3389\/fmolb.2020.584228","journal-title":"Front Mol Biosci"},{"key":"2719_CR55","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/ijms22020496","volume":"22","author":"MN Arroyo","year":"2021","unstructured":"Arroyo MN, Green JA, Cnop M, Igoillo-Esteve M (2021) tRNA biology in the pathogenesis of diabetes: role of genetic and environmental factors. Int J Mol Sci 22:496. https:\/\/doi.org\/10.3390\/ijms22020496","journal-title":"Int J Mol Sci"},{"key":"2719_CR56","doi-asserted-by":"publisher","first-page":"e21383","DOI":"10.1097\/MD.0000000000021383","volume":"99","author":"X Liu","year":"2020","unstructured":"Liu X, Liang J, Geng H, Xu W, Teng F, Yang M (2020) Association of the CDKAL1 polymorphism rs10946398 with type 2 diabetes mellitus in adults: a meta-analysis. Med (Baltim) 99:e21383. https:\/\/doi.org\/10.1097\/MD.0000000000021383","journal-title":"Med (Baltim)"},{"key":"2719_CR57","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2147\/DMSO.S225968","volume":"13","author":"K Vatankhah Yazdi","year":"2020","unstructured":"Vatankhah Yazdi K, Kalantar SM, Houshmand M, Rahmanian M, Manaviat MR, Jahani MR, Kamalidehghan B, Almasi-Hashiani A (2020) SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are associated with type 2 diabetes mellitus in Iranian patients. Diabetes Metab Syndr Obes 13:897\u2013906. https:\/\/doi.org\/10.2147\/DMSO.S225968","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2719_CR58","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/hmg\/ddu191","volume":"23","author":"B Zhou","year":"2014","unstructured":"Zhou B, Wei FY, Kanai N, Fujimura A, Kaitsuka T, Tomizawa K (2014) Identification of a splicing variant that regulates type 2 diabetes risk factor CDKAL1 level by a coding-independent mechanism in human. Hum Mol Genet 23:5017\u20135024. https:\/\/doi.org\/10.1093\/hmg\/ddu191","journal-title":"Hum Mol Genet"},{"key":"2719_CR59","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/biology12060871","volume":"12","author":"FR Rahmadanthi","year":"2023","unstructured":"Rahmadanthi FR, Maksum IP (2023) Transfer RNA mutation associated with type 2 diabetes mellitus. Biology (Basel) 12:871. https:\/\/doi.org\/10.3390\/biology12060871","journal-title":"Biology (Basel)"},{"key":"2719_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094843","volume":"23","author":"J-H Lee","year":"2022","unstructured":"Lee J-H, Lee J (2022) Endoplasmic reticulum (ER) stress and its role in pancreatic \u03b2-cell dysfunction and senescence in type 2 diabetes. Int J Mol Sci 23:4843. https:\/\/doi.org\/10.3390\/ijms23094843","journal-title":"Int J Mol Sci"},{"key":"2719_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042039","volume":"25","author":"S Suthon","year":"2024","unstructured":"Suthon S, Tangjittipokin W (2024) Mechanisms and physiological roles of polymorphisms in gestational diabetes mellitus. Int J Mol Sci 25:2039. https:\/\/doi.org\/10.3390\/ijms25042039","journal-title":"Int J Mol Sci"},{"key":"2719_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2020.100767","volume":"26","author":"AK Verma","year":"2020","unstructured":"Verma AK, Beg MMA, Khan NA, Goyal Y, Dev K, Joshi PC (2020) CDKAL1 (rs10946398) and TCF7L2 (rs7903146) gene polymorphisms and their association with risk of type-2 diabetes mellitus in population of Uttarakhand, India. Meta Gene 26:100767. https:\/\/doi.org\/10.1016\/j.mgene.2020.100767","journal-title":"Meta Gene"},{"key":"2719_CR63","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMcibr1109442","volume":"365","author":"RJ Kaufman","year":"2011","unstructured":"Kaufman RJ (2011) Beta-cell failure, stress, and type 2 diabetes. N Engl J Med 365:1931\u20131933. https:\/\/doi.org\/10.1056\/NEJMcibr1109442","journal-title":"N Engl J Med"},{"key":"2719_CR64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/00325481.2024.2328513","volume":"136","author":"A Kyriakidou","year":"2024","unstructured":"Kyriakidou A, Kyriazou AV, Koufakis T, Vasilopoulos Y, Avramidis I, Baltagiannis S, Goulis DG, Kotsa K (2024) Association between variants in TCF7L2, CTRB1\/2 and GLP-1R genes and response to therapy with GLP-1 receptor agonists in patients with type 2 diabetes. Postgrad Med 136:218\u2013225. https:\/\/doi.org\/10.1080\/00325481.2024.2328513","journal-title":"Postgrad Med"},{"key":"2719_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002654","volume":"15","author":"MS Udler","year":"2018","unstructured":"Udler MS, Kim J, von Grotthuss M, Bon\u00e0s-Guarch S, Cole JB, Chiou J et al (2018) Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med 15:e1002654. https:\/\/doi.org\/10.1371\/journal.pmed.1002654","journal-title":"PLoS Med"},{"key":"2719_CR66","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2337\/dc21-1395","volume":"45","author":"D DiCorpo","year":"2022","unstructured":"DiCorpo D, LeClair J, Cole JB, Sarnowski C, Ahmadizar F, Bielak LF et al (2022) Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts. Diabetes Care 45:674\u2013683. https:\/\/doi.org\/10.2337\/dc21-1395","journal-title":"Diabetes Care"},{"key":"2719_CR67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6:361\u2013369. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2719_CR68","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.2337\/db07-0440","volume":"56","author":"ER Pearson","year":"2007","unstructured":"Pearson ER, Donnelly LA, Kimber C, Whitley A, Doney ASF, McCarthy MI, Hattersley AT, Morris AD, Palmer CNA (2007) Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes 56:2178\u20132182. https:\/\/doi.org\/10.2337\/db07-0440","journal-title":"Diabetes"},{"key":"2719_CR69","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00125-014-3276-y","volume":"57","author":"H Zimdahl","year":"2014","unstructured":"Zimdahl H, Ittrich C, Graefe-Mody U, Boehm BO, Mark M, Woerle HJ, Dugi KA (2014) Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin. Diabetologia 57:1869\u20131875. https:\/\/doi.org\/10.1007\/s00125-014-3276-y","journal-title":"Diabetologia"},{"key":"2719_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3109","volume":"35","author":"GC Mannino","year":"2019","unstructured":"Mannino GC, Andreozzi F, Sesti G (2019) Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine. Diabetes Metab Res Rev 35:e3109. https:\/\/doi.org\/10.1002\/dmrr.3109","journal-title":"Diabetes Metab Res Rev"},{"key":"2719_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.33549\/physiolres.932228","volume":"61","author":"Z Schroner","year":"2012","unstructured":"Schroner Z, Javorsk\u00fd M, Halu\u0161kov\u00e1 J, Klim\u010d\u00e1kov\u00e1 L, Babjakov\u00e1 E, Fabianov\u00e1 M, Slab\u00e1 E, Koz\u00e1rov\u00e1 M, Tk\u00e1\u010d I (2012) Variation in CDKAL1 gene is associated with therapeutic response to sulphonylureas. Physiol Res 61:177\u2013183. https:\/\/doi.org\/10.33549\/physiolres.932228","journal-title":"Physiol Res"},{"key":"2719_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2024.103171","volume":"36","author":"R Farzan","year":"2024","unstructured":"Farzan R, Alshammari FD, Alanazi F, Alessa R, Alanazi K, Alharbi M (2024) Effect of rs10440833 polymorphism in the CDKAL1 gene on insulin secretion in type 2 diabetes patients. J King Saud Univ Sci 36:103171. https:\/\/doi.org\/10.1016\/j.jksus.2024.103171","journal-title":"J King Saud Univ Sci"},{"key":"2719_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ph18091261","volume":"18","author":"Z Song","year":"2025","unstructured":"Song Z, Tang Y, Peng M, Han R, He P (2025) Pharmacogenomics of tirzepatide: genomic insights into dual GIP\/GLP-1 agonist response in type 2 diabetes and atherosclerosis. Pharmaceuticals (Basel) 18:1261. https:\/\/doi.org\/10.3390\/ph18091261","journal-title":"Pharmaceuticals (Basel)"},{"key":"2719_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/genes16010022","volume":"16","author":"Y Timasheva","year":"2025","unstructured":"Timasheva Y, Belyaeva O, Sorokina A, Karonova T, Vasilieva E, Shlyakhto E et al (2025) Polygenic score approach to predicting risk of metabolic disorders and type 2 diabetes. Genes (Basel) 16:22. https:\/\/doi.org\/10.3390\/genes16010022","journal-title":"Genes (Basel)"},{"key":"2719_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01748-y","volume":"17","author":"A Sami","year":"2025","unstructured":"Sami A, Javed A, Uzun Ozsahin D, Ozsahin I, Muhammad K, Waheed Y et al (2025) Genetics of diabetes and its complications: a comprehensive review. Diabetol Metab Syndr 17:185. https:\/\/doi.org\/10.1186\/s13098-025-01748-y","journal-title":"Diabetol Metab Syndr"},{"key":"2719_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/medsci13030180","volume":"13","author":"SJ Shimu","year":"2025","unstructured":"Shimu SJ, Mahir JUK, Shakib FAF, Ridoy AA, Samir RA, Jahan N et al (2025) Metabolic reprogramming through polyphenol networks: a systems approach to metabolic inflammation and insulin resistance. Med Sci (Basel) 13:180. https:\/\/doi.org\/10.3390\/medsci13030180","journal-title":"Med Sci (Basel)"},{"key":"2719_CR77","unstructured":"Kreienkamp RJ, Voight BF, Gloyn AL, Udler MS (2023) Genetics of type 2 diabetes. In: Lawrence JM, Casagrande SS, Herman WH (eds) Diabetes in America [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda (MD). Initial posting: 20 Dec 2023. Accessed 18 Jan 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK597726\/"},{"key":"2719_CR78","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.cmet.2023.09.013","volume":"35","author":"D Xue","year":"2023","unstructured":"Xue D, Narisu N, Taylor DL, Zhang M, Grenko C, Taylor HJ et al (2023) Functional interrogation of twenty type 2 diabetes-associated genes using isogenic human embryonic stem cell-derived \u03b2-like cells. Cell Metab 35:1897-1914e.e11. https:\/\/doi.org\/10.1016\/j.cmet.2023.09.013","journal-title":"Cell Metab"},{"key":"2719_CR79","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41576-023-00678-7","volume":"25","author":"S Fatumo","year":"2024","unstructured":"Fatumo S (2024) Including diverse populations enhances the discovery of type 2 diabetes loci. Nat Rev Genet 25:82. https:\/\/doi.org\/10.1038\/s41576-023-00678-7","journal-title":"Nat Rev Genet"},{"key":"2719_CR80","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/biomedicines13020447","volume":"13","author":"D Dhieb","year":"2025","unstructured":"Dhieb D, Al-Bourini A, Saad R, Al-Rubeaan K (2025) Harnessing pharmacomultiomics for precision medicine in type 2 diabetes: from genetic association to actionable stratification. Biomedicines 13:447. https:\/\/doi.org\/10.3390\/biomedicines13020447","journal-title":"Biomedicines"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02719-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:32:51Z","timestamp":1792567971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02719-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":80,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2719"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02719-z","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}